BUSCOPAN COMPOSITUM LONG-ACTING SPASMOLYTIC & ANALGESIC

Main information

  • Trade name:
  • BUSCOPAN COMPOSITUM LONG-ACTING SPASMOLYTIC & ANALGESIC
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • BUSCOPAN COMPOSITUM LONG-ACTING SPASMOLYTIC & ANALGESIC
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | DOG | HORSE | HORSE FOAL | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | G
  • Therapeutic area:
  • ALIMENTARY SYSTEM
  • Therapeutic indications:
  • ANALGESIC | ANTIPYRETIC | COLIC | MUSCLE RELAXANT | SEDATIVE | SPASMOLYTIC

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 35923
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

22-7-2018

We must address data gaps on tech for women’s health. Our new Women’s Health Technologies Strategically Coordinated Registry Network  https://bit.ly/2L4Tqsx  provides more evidence on areas as uterine fibroids, pelvic floor disorders & female long-acting

We must address data gaps on tech for women’s health. Our new Women’s Health Technologies Strategically Coordinated Registry Network https://bit.ly/2L4Tqsx  provides more evidence on areas as uterine fibroids, pelvic floor disorders & female long-acting

We must address data gaps on tech for women’s health. Our new Women’s Health Technologies Strategically Coordinated Registry Network https://bit.ly/2L4Tqsx  provides more evidence on areas as uterine fibroids, pelvic floor disorders & female long-acting reversible contraception pic.twitter.com/TAWmVh99oL

FDA - U.S. Food and Drug Administration